Personalized glucose-lowering effect of chiglitazar in type 2 diabetes

Chiglitazar (carfloglitazar) is a peroxisome proliferator-activated receptor pan-agonist presenting non-inferior glucose-lowering efficacy with sitagliptin in patients with type 2 diabetes. To delineate the subgroup of patients with greater benefit from chiglitazar, we conducted a machine learning-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qi, Zou, Xiantong, Chen, Yingli, Gao, Leili, Cai, Xiaoling, Zhou, Lingli, Gao, Fei, Zhou, Jian, Jia, Weiping, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628820/
https://www.ncbi.nlm.nih.gov/pubmed/37942014
http://dx.doi.org/10.1016/j.isci.2023.108195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628820/
https://www.ncbi.nlm.nih.gov/pubmed/37942014
http://dx.doi.org/10.1016/j.isci.2023.108195

Ejemplares similares